Imprivata Secures Consecutive Best in KLAS Award, Signaling Healthcare Access Management Dominance

  • Imprivata Enterprise Access Management (EAM) has been named the 2026 Best in KLAS for Access Management, marking the second consecutive year it has received the award.
  • The award is based on direct feedback from healthcare provider organizations, highlighting customer satisfaction and product performance.
  • Imprivata acquired Verosint, indicating a strategic focus on adaptive and risk-based access controls.
  • Customer testimonials emphasize the product's reliability, ease of configuration, and strong support services.
  • KLAS Research uses interviews with thousands of healthcare providers to determine the rankings.

Imprivata's consecutive Best in KLAS awards underscore the critical role of secure access management in the healthcare sector, which is increasingly reliant on digital workflows and facing heightened cybersecurity threats. The acquisition of Verosint signals a strategic move towards more sophisticated security measures, reflecting a broader industry trend towards adaptive and risk-based access controls. The company's success is tied to the ongoing digital transformation of healthcare and the need for solutions that balance security, compliance, and operational efficiency.

Integration Risk
The successful integration of Verosint's technology and personnel will be crucial to realizing the planned innovations in adaptive and risk-based access, and any missteps could impact Imprivata's competitive advantage.
Competitive Landscape
While Imprivata holds the Best in KLAS award for two years running, the rapidly evolving access management landscape means competitors will likely accelerate innovation to challenge Imprivata's market position.
Customer Retention
Continued reliance on positive customer feedback, as evidenced by the KLAS awards and testimonials, suggests Imprivata’s ability to maintain its position hinges on sustaining high levels of customer satisfaction and loyalty.